MedTrace Logo

Effect of DT56a (Femarelle) on the Coagulation System in the Treatment of Postmenopausal Women

NCT00883272 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2023-08-22

No results posted yet for this study

Summary

The purpose of this study is to determine if Femeralle (DT56a) has an effect on the coagulation system, measured by platelet adhesion and aggregation, of normal and thrombophilic postmenopausal women.

Conditions

Interventions

DIETARY_SUPPLEMENT

DT56a (Femarelle) [Se-cure pharmaceuticals, Dalton, Israel]

a unique enzymatic isolate of the active complex in Tofu

Sponsors & Collaborators

Principal Investigators

  • Lila Nachtigall, MD · NYU Langone Health

Eligibility

Min Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2009-01-31
Completion
2009-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00883272 on ClinicalTrials.gov